List of Monoclonal Antobodies• Abciximab ReoPro 1994 chimeric inhibition of glycoprotein IIb/IIIa Cardiovascular disease 
• Infliximab  chimeric I inhibition of TNF-a Inflammatory diseases 
.Adalimumab human inhibition of TNF-a signalling Inflammatory diseases 
• Natalizumab  humanized T cell VLA4 receptor Inflammatory diseases . (esp autoimmune-related multiple sclerosis therapy) 
• Omalizumab  humanized Ig E Inflammatory diseases . (mainly allergy-related asthma therapy) 
• Eculizumab humanized complement C5 Inflammatory diseases . (PNH)
• Efalizumab  humanized CD11a Inflammatory diseases . (psoriasis) 
• Alemtuzumab  humanized CD52 CLL 
Gemtuzumab  humanized CD33 AML . (with calicheamicin) 
• Ri - tuximab Rituxan,  chimeric CD20 NHL 
Ibritumomab tiuxetan  murine CD20 NHL (with yttrium-90 or indium-111) 
Tostumomab  murine CD20 NHL
.Daclizumab  humanized IL-2 receptor Transplant rejection 
Basiliximab  chimeric IL-2 receptor Transplant rejection 
Muromonab  murine CD3 Receptor Transplant rejection
• Bevaciz umab humanized vascular endothelial growth factor Colorectal cancer 
Panitumumab human epidermal growth factor receptor Colorectal cancer 
Cetuximab  chimeric epidermal growth factor receptor Colorectal cancer 
• Ranibizumab  humanized vascular endothelial growth factor Macular degeneration 
• Palivizumab  humanized epitope of F protein of RSV Viral infection (espRSV) 
• Trastuzumab  humanized ErbB2 Breast cancer
-mab suffix monoclonal antibody.
if immediately before mab----u--its humane derived
. ---mo--its murine
. ----i----its chimeric.